Metabolic Reprogramming in Deep Vein Thrombosis: A Novel Therapeutic Avenue Beyond Anticoagulation
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former president of ISTH, recently shared an honoring post on X:
”Metabolic pathways in deep vein thrombosis: a new frontier for therapeutic intervention. This is a fascinating paper. Congratulations to the authors!”
Read the full article here.
Traditional anticoagulants do their job well—until they start doing it a little too well, turning the prevention of clots into a new risk: bleeding, especially when you need them the most over time.
In the new study published by Ivan Budnik et al. in Blood Journal by American Society of Hematology (ASH), metabolic pathways responsible for clot formation are seen as alternatives for treatment focus.
Preclinical studies reveal that targeting metabolic pathways can reduce thrombus formation without compromising hemostasis.
This metabolism-focused paradigm offers promising therapeutic potential, aiming to prevent or mitigate DVT while minimizing bleeding risk, and underscores the need for translational research into metabolic interventions as adjuncts or alternatives to anticoagulants.
Hemostasis Today, your daily update on scientific advancements in thrombosis and hemostasis field.
-
Jul 5, 2025, 17:24Bleeding Disorders in 2035: Michael Makris is Future-Focused at HABIT Summit 2025
-
Jul 5, 2025, 16:32EHC Unveils New ERIN Identity: Supporting Individuals with Extremely Rare Bleeding Disorders
-
Jul 5, 2025, 16:30Calling Physiotherapists: Contribute to Shaping Care for Women with Bleeding Disorders by Sharing Insights on Physical Health and Physiotherapy
-
Jul 5, 2025, 16:26Access ISTH 2025 Congress On-Demand: 30 Days of Virtual Learning Available Now
-
Jul 5, 2025, 16:17Thrombosis Canada Wants Your Voice: Did You Know 1 in 5 Cancer Patients Will Experience a Blood Clot (VTE)?
-
Jul 6, 2025, 16:23Metabolic Reprogramming in Deep Vein Thrombosis: A Novel Therapeutic Avenue Beyond Anticoagulation
-
Jul 5, 2025, 17:38Late-Window Stroke: Hyperglycemia Doesn’t Alter EVT Benefit
-
Jul 5, 2025, 17:33Discharged, But Not Safe: Uncovering Hidden Risks of Anticoagulation for Post-Hospital Bleeding
-
Jul 2, 2025, 16:51Research Tuesday from SVIN: IV Thrombolysis in Cervical Artery Dissection—A Safer Path Home?
-
Jul 2, 2025, 05:34Redefining Life with Catastrophic Antiphospholipid Syndrome: Mark Hall’s Journey at U-M Health
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jul 6, 2025, 15:02Patients as Experts: EHC Calls for Early Involvement in HTA Systems
-
Jul 6, 2025, 14:56Missed ISTH 2025? Congress Daily Has You Covered
-
Jun 30, 2025, 15:31Don’t Miss the Advanced Haemostasis and Thrombosis Course Led by Expert Tutors - Blood Academy
-
Jun 26, 2025, 14:33ISTH Pulse Podcast Episode with Vasculearn Network
-
Jun 22, 2025, 11:27The ISTH Congress Daily News Team Interviews Rob Montgomery